{"disease":{"id":"coeliac-disease","name":"coeliac disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07364461","title":"Diagnostic Accuracy of IgA Anti-transglutaminase Antibodies Measured by CLIA for Predicting Villous Atrophy in Coeliac Disease","phase":"","overall_status":"COMPLETED","enrollment_count":765,"lead_sponsor_name":"Hospital Mutua de Terrassa","has_results":false},{"nct_id":"NCT06930924","title":"Supporting Children and Young People to Live Well With Coeliac Disease: A RCT","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":350,"lead_sponsor_name":"University of Surrey","has_results":false},{"nct_id":"NCT06557772","title":"A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":229,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT05786183","title":"Rapid Technique for the Detection of Intestinal Anti-transglutaminase Antibodies","phase":"","overall_status":"UNKNOWN","enrollment_count":163,"lead_sponsor_name":"IRCCS Burlo Garofolo","has_results":false},{"nct_id":"NCT04604795","title":"Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GSK3915393 in Healthy Participants and to Evaluate the Interaction Between GSK3915393 and Grapefruit Juice and Itraconazole","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT07172555","title":"Virtual Dietetic Interventions in Patients With Coeliac","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Sheffield Teaching Hospitals NHS Foundation Trust","has_results":false},{"nct_id":"NCT06001177","title":"A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA","has_results":true},{"nct_id":"NCT03543540","title":"Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"ImmusanT, Inc.","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}